Wellness Update: Asia: Hologic's CEO Discusses Q2 2011 Results - Earnings Call Transcript - Seeking Alpha

Hologic's CEO Discusses Q2 2011 Results - Earnings Call Transcript - Seeking Alpha: "Turning now to some key points of interest, I'd like to provide you some details on the FDA approval and commercial launch of our Dimensions 3D system. As you know, the Dimensions 3D received approval on February 11 of this year. We're very proud to be the first company that has an FDA-approved product in the groundbreaking technology for both screening and diagnostic indications. Moreover, this product was approved on the basis that it's superior to 2D digital mammography. We launched the product in the U.S. immediately following approval. Our sales force was well-prepared for the launch, and we had already begun to provide comprehensive physician training. Since approval, we have successfully upgraded a number of domestic systems to Dimensions 3D and are extremely pleased with the early uptake so far and the high level of excitement and enthusiasm from our customers and potential customers. In fact, we are hearing that a large number of customers want the product as soon as their capital budgets permit so that they can remain competitive within their local communities."